ASTELLAS PHARMA UNSP.ADR (YPHA) — Cash Flow Reinvestment Rate
ASTELLAS PHARMA UNSP.ADR (YPHA) has a Cash Flow Reinvestment Rate of 0.36x as of March 2025, reinvesting €70.25 Billion (capex €57.33 Billion plus investments €12.92 Billion) from operating cash flow of €194.51 Billion. Check ASTELLAS PHARMA UNSP.ADR cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ASTELLAS PHARMA UNSP.ADR Cash Flow Reinvestment Rate (2022–2025)
Historical reinvestment intensity for ASTELLAS PHARMA UNSP.ADR across 4 annual periods. Explore ASTELLAS PHARMA UNSP.ADR (YPHA) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for ASTELLAS PHARMA UNSP.ADR (2022–2025)
Year-by-year capital reinvestment analysis for ASTELLAS PHARMA UNSP.ADR. For live market cap and broader valuation context, see ASTELLAS PHARMA UNSP.ADR stock valuation.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.36x | €70.25 Billion | €194.51 Billion | €57.33 Billion | ▼ -24.5% |
| 2024 | 0.48x | €82.50 Billion | €172.47 Billion | €82.50 Billion | ▲ +55.0% |
| 2023 | 0.31x | €101.17 Billion | €327.77 Billion | €88.54 Billion | ▼ -3.1% |
| 2022 | 0.32x | €82.02 Billion | €257.44 Billion | €76.45 Billion | — |